Liver News and Research

RSS

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Researchers present the mechanisms by which SARS-CoV-2 could infect the brain and affect memory.

5 Jul 2023

Growth factor study reveals potential breakthrough in obesity management

Study discusses the effects of a growth factor that showed promising results in mice in an obesity trial.

4 Jul 2023

Study sheds light on progress and gaps in hepatitis C clearance cascade

Researchers described the hepatitis C virus (HCV) elimination cascade during the direct-acting antivirals (DAA) era.

4 Jul 2023

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Activation of the NRF2 transcription factor shows promise as a potential treatment approach for non-alcoholic fatty liver disease (NAFLD), a condition associated with oxidative stress and liver damage. By screening FDA-approved drugs, researchers identified six compounds that enhanced NRF2 activity and demonstrated protective effects against oxidative stress and lipid accumulation.

3 Jul 2023

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine.

3 Jul 2023

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), using an automated deep-learning AI tool, as well as weight-based volumetric thresholds, might afford large-scale evaluation for splenomegaly on CT examinations performed for any indication.

3 Jul 2023

Covid deaths plummet in England, but dementia and heart disease remain a concern

New Government figures show a higher than average number of deaths last month. Dementia was the biggest killer in England and heart disease in Wales.

1 Jul 2023

Spanish researchers develop new immunotherapy combination for liver cancer

Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.

1 Jul 2023

Deep learning model could help identify high-risk patients with community-acquired pneumonia

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), a deep learning-based model using initial chest radiographs predicted 30-day mortality in patients with community-acquired pneumonia (CAP), improving upon the performance of an established risk prediction tool (i.e., CURB-65 score).

30 Jun 2023

Tiny sea creature offers new clues to regeneration and aging

Insights into healing and aging were discovered by National Institutes of Health researchers and their collaborators, who studied how a tiny sea creature regenerates an entire new body from only its mouth.

30 Jun 2023

The epidemiology of the Streptococcus agalactiae bacterium (group B Streptococcus [GBS]) in Southeast Asia

Researchers detected the presence of a Streptococcus agalactiae (group B Streptococcus) sequence type (ST) 283.

30 Jun 2023

Staging laparoscopy enables early detection of pancreatic cancer: Study

A study published in the Journal of the American College of Surgeons reveals that performing a minor surgical procedure on patients newly diagnosed with pancreatic cancer helps to identify cancer spread early and determine the stage of cancer

30 Jun 2023

A healthy lifestyle reduces risk of developing severe liver disease

Researchers investigate the correlation between a healthy lifestyle and Life’s Essential 8 scores in new-onset severe non-alcoholic fatty liver disease.

29 Jun 2023

WHO to declare artificial sweetener aspartame as possible carcinogen

The World Health Organization recently indicated that aspartame will likely be declared a “possible carcinogen to humans.”

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Understanding the biological effects of SARS-CoV-2 persistence in children

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Jun 2023

SickKids researchers discover new way to attack treatment-resistant TB infections

In the face of growing antibiotic resistance among bacterial infections, scientists at The Hospital for Sick Children (SickKids) have delved into the molecular science behind treatment-resistant tuberculosis.

28 Jun 2023

Alcohol use raises the risks of 61 diseases in Chinese men

Alcohol consumption increases the risks of over 60 diseases in Chinese men, including many diseases not previously linked to alcohol, according to a new study by researchers from Oxford Population Health, Peking University, and the Chinese Academy of Medical Sciences. The study is published today in Nature Medicine.

28 Jun 2023

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem.

28 Jun 2023

New nanoparticle could improve the delivery of mRNA-based vaccines

Johns Hopkins Medicine scientists say they have developed a nanoparticle - an extremely tiny biodegradable container - that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for infectious diseases such as COVID-19, and vaccines for treating non-infectious diseases including cancer.

28 Jun 2023

Liver News and Research

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Growth factor study reveals potential breakthrough in obesity management

Study sheds light on progress and gaps in hepatitis C clearance cascade

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

Covid deaths plummet in England, but dementia and heart disease remain a concern

Spanish researchers develop new immunotherapy combination for liver cancer

Deep learning model could help identify high-risk patients with community-acquired pneumonia

Tiny sea creature offers new clues to regeneration and aging

The epidemiology of the Streptococcus agalactiae bacterium (group B Streptococcus [GBS]) in Southeast Asia

Staging laparoscopy enables early detection of pancreatic cancer: Study

A healthy lifestyle reduces risk of developing severe liver disease

WHO to declare artificial sweetener aspartame as possible carcinogen

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Understanding the biological effects of SARS-CoV-2 persistence in children

SickKids researchers discover new way to attack treatment-resistant TB infections

Alcohol use raises the risks of 61 diseases in Chinese men

Single-cell transcriptomic analysis reveals specific cellular signatures for kidney transplant rejection

New nanoparticle could improve the delivery of mRNA-based vaccines

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News